Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone
Keywords: Serotonin (5-hydroxytryptamine, 5-HT); Microdialysis; Frontal cortex; Paroxetine; N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(pyridinyl)cyclohexanecarboxamide) (WAY-100635); 5-HT1A receptor; 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT);